Hello, Earnings Season

Earn While You Learn! ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ [EARN WHILE YOU LEARN! JOIN OUR FREE LIVE TRADING SESSION!]( Hello investor, Hello, Earnings Season The S&P 500 and the Nasdaq are at record highs, and Wall Street is pondering on whether there’s still juice left in the rally. Last Friday’s jobs report showed a 206,000 increase in nonfarm payrolls in June, while the unemployment rate increased to 4.1%. Both data points supported the thesis that rate cuts are coming soon. Traders boosted the odds of a September rate cut to about 77% after the jobs report. Surely, there are some signs that the economy is cooling. That’s expected. But traders are watching to see if it can cool down gradually — without tipping the economy into a recession. - “On one hand, the downward revisions to prior months and the rise in the unemployment rate raises the odds of a September Fed rate cut — bond markets are certainly celebrating this,” said Seema Shah, chief global strategist at Principal Asset Management. - “But those same figures cannot help but prompt a twinge of concern about the direction of the U.S. economy. The broad host of economic data all point to a softening — today’s report adds to that picture.” Seema Shah, chief global strategist at Principal Asset Management (Source: CNBC) As for this week’s catalysts, June’s consumer price index will be released on Thursday. The earnings season will kick off with reports from JPMorgan Chase, Wells Fargo and Citi on Friday. So, expect the earnings season to take the spotlight in the next few weeks. Top Medical Device Maker Is Scaling Fast With A Drug-Free Opioid Alternative Today’s Pick: Zynex, Inc. (ZYXI) Recently, some scholars have debated about whether Albert Einstein actually said that compounding interest is the eighth wonder of the universe. No matter. Any time you can find a stock for your portfolio that’s compounding nicely, it’s a good candidate for your portfolio. This is a phenomenal grower: (Source: Zynex) Besides one bad quarter, Zynex never failed to grow year-to-year quarter under 11% per quarter since 2017. What exactly does Zynex do? They focus on electrotherapy through three primary lines of business. First, electrotherapy for strokes, spinal cord injuries, and traumatic brain injuries. Second, electrotherapy for digestive issues. (Source: Zynex) Third, their NexWave pain management system might be their biggest opportunity. The company is marketing the product as an alternative to opioids for pain management. The timing is perfect. Pharmaceutical companies are quietly working towards a multi-billion dollar settlement for their opioid business practices. Even better, their treatments lend themselves to recurring revenue. It’s not just a one-time device sale. And these are widely profitable. Zynex has earned gross margins north of 79% the past five years. (Source: Zynex) Best of all: Their NexWave competition all went out of business. In 2016, the inspector general audited Zynex and both of their competitors. Zynex passed. The other electrotherapy pain management companies didn’t -- they shut down after millions of dollars in fines. CEO Thomas Sandgaard’s reaction? - “We literally have no competition left.” Zynex checks a lot of boxes financially. Here’s just a few of the highlights: - Insiders still hold a remarkable 51% of shares. We love it when we see this. Leadership has a financial incentive to increase shareholder value. Then their gains become your gains. - Their market cap is still just $283 million. Lots more capital could flow in as long as they continue to grow. - They boast a current ratio of 3.59. Cash on the balance sheet lets them invest in new opportunities as they arise. Bottom Line: This is one of the most exciting growth stocks that investors are overlooking. If you want a bet on smaller-cap companies, this stock is the one to look at. [EARN WHILE YOU LEARN! JOIN OUR FREE LIVE TRADING SESSION!](       © All Rights Reserved, Trade Alliance [Unsubscribe]( | [Manage Preferences](